Cumberland Pharmaceuticals Ownership | Who Owns Cumberland Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Cumberland Pharmaceuticals Ownership Summary


Cumberland Pharmaceuticals is owned by 10.37% institutional investors, 41.53% insiders, and 48.10% retail investors. Millennium management is the largest institutional shareholder, holding 5.42% of CPIX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.01% of its assets in Cumberland Pharmaceuticals shares.

CPIX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCumberland Pharmaceuticals10.37%41.53%48.10%
SectorHealthcare Stocks 279.19%10.58%-189.76%
IndustrySpecialty & Generic Drug Manufacturers Stocks2774.73%11.67%-2686.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management809.90K5.42%$3.43M
Ikarian capital740.00K4.95%$3.13M
Renaissance507.16K3.61%$1.20M
Vanguard group374.25K2.66%$886.98K
Dimensional fund advisors lp272.97K1.94%$646.94K
Acadian asset management188.16K1.34%$444.00K
Bridgeway capital management184.16K1.31%$436.45K
Blackrock110.56K0.78%$169.16K
Bank of new york mellon75.27K0.54%$178.39K
Geode capital management74.31K0.53%$176.14K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital740.00K0.39%$3.13M
Bridgeway capital management184.16K0.01%$436.45K
Renaissance507.16K0.00%$1.20M
Millennium management809.90K0.00%$3.43M
Acadian asset management188.16K0.00%$444.00K
Cresset asset management22.27K0.00%$52.79K
Dimensional fund advisors lp272.97K0.00%$646.94K
Two sigma investments, lp37.65K0.00%$89.23K
Capital advisors437.000.00%$1.00K
Bank of america corp /de/67.00-$103.00

Top Buyers

HolderShares% AssetsChange
Millennium management809.90K0.00%809.90K
Ikarian capital740.00K0.39%740.00K
Two sigma investments, lp37.65K0.00%18.27K
Cresset asset management22.27K0.00%1.00K
Capital advisors437.000.00%437.00

Top Sellers

HolderShares% AssetsChange
Bridgeway capital management184.16K0.01%-102.50K
Blackrock funding, inc. /de42.58K--67.49K
Two sigma advisers, lp---23.00K
Renaissance507.16K0.00%-21.00K
Dimensional fund advisors lp272.97K0.00%-11.04K

New Positions

HolderShares% AssetsChangeValue
Millennium management809.90K0.00%809.90K$3.43M
Ikarian capital740.00K0.39%740.00K$3.13M
Capital advisors437.000.00%437.00$1.00K

Sold Out

HolderChange
Advisor group-100.00
Innealta capital-948.00
Tower research capital llc (trc)-2.22K
Oakworth capital-3.05K
Schonfeld strategic advisors-10.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20253-85.71%1,549,897-15.86%106.04%3-25.00%--100.00%
Dec 31, 202421-8.70%1,842,038-9.87%136.20%4-55.56%10150.00%
Sep 30, 202423-4.17%2,043,812-1.62%146.70%950.00%4-20.00%
Jun 30, 202424-2,077,457-3.95%146.44%620.00%5-44.44%
Mar 31, 202424-4.00%2,162,869-1.58%156.39%5-37.50%950.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF280.82K2.01%-
Vanguard Total Stock Mkt Idx Inv280.82K1.88%-
Bridgeway Ultra-Small Company133.07K0.89%-
Vanguard Institutional Extnd Mkt Idx Tr126.56K0.85%-
IMC US Ultra Micro Cap79.25K0.53%-
DFA US Targeted Value I63.30K0.45%-
DFA US Micro Cap I47.77K0.34%-
Bridgeway Ultra-Small Company Market49.89K0.33%-
Fidelity Extended Market Index43.88K0.31%4.58K
Pleiades Small Cap Equity A39.62K0.28%39.62K

Recent Insider Transactions


DateNameRoleActivityValue
May 29, 2025Krogulski Kenneth-Buy$254.70
May 28, 2025Krogulski Kenneth-Buy$255.60
May 27, 2025Krogulski Kenneth-Buy$237.15
May 23, 2025Krogulski Kenneth-Buy$231.30
May 30, 2025Krogulski Kenneth-Buy$221.85

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q1--
2024 Q3--
2024 Q2--
2024 Q1--

CPIX Ownership FAQ


Who Owns Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals shareholders are primarily institutional investors at 10.37%, followed by 41.53% insiders and 48.10% retail investors. The average institutional ownership in Cumberland Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 2774.73%, which Cumberland Pharmaceuticals falls below.

Who owns the most shares of Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals’s largest shareholders are Millennium management (809.9K shares, 5.42%), Ikarian capital (740K shares, 4.95%), and Renaissance (507.16K shares, 3.61%). Together, they hold 13.98% of Cumberland Pharmaceuticals’s total shares outstanding.

Does Blackrock own Cumberland Pharmaceuticals?

Yes, BlackRock owns 0.78% of Cumberland Pharmaceuticals, totaling 110.56K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 169.16K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.39% of its assets in 740K Cumberland Pharmaceuticals shares, valued at 3.13M$.

Who is the top mutual fund holder of Cumberland Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cumberland Pharmaceuticals shares, with 2.01% of its total shares outstanding invested in 280.82K Cumberland Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools